Citation Impact
Citing Papers
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
Fatty liver in familial hypobetalipoproteinemia
2004
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
2004
Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up
1991
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
1993
ACAMPROSATE AND RELAPSE PREVENTION IN THE TREATMENT OF ALCOHOL DEPENDENCE: A PLACEBO-CONTROLLED STUDY
2000
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
1992
HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women
1997
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches
2004
Hyperinsulinemia Induces Myocardial Infarctions and Arteriolar Medial Hypertrophy in Spontaneously Hypertensive Rats
1997
Incidence and Direct Medical Costs of Hospitalizations due to Osteoporotic Fractures in Switzerland
1997
Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
1990
Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians
2008
Body fat distribution, insulin resistance, and metabolic diseases
1997
Metabolic syndrome and target organ damage in untreated essential hypertensives
2004
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Pharmacological Treatment of Alcohol Dependence
1999
Body mass index as a predictor of fracture risk: A meta-analysis
2005
Are Metabolic Risk Factors One Unified Syndrome? Modeling the Structure of the Metabolic Syndrome X
2003
Serum Uric Acid and Cardiovascular Mortality
2000 Standout
The metabolic syndrome: is this diagnosis necessary?1,2
2006
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
The metabolic syndrome
2010 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Relationship between Generalized and Upper Body Obesity to Insulin Resistance in Asian Indian Men1
1999
Serum Uric Acid and Risk of Coronary Heart Disease
2000
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
1996
Uric Acid and Cardiovascular Risk
2008 Standout
Prediction of fracture from low bone mineral density measurements overestimates risk
2000
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome
1991
Serum Insulin and Other Cardiovascular Risk Indicators in Children, Adolescents and Young Adults
1991
Alcohol and public health
2005 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.
1997
Intervention thresholds for osteoporosis
2002
Insulin as a predictor of coronary heart disease: Interaction with apolipoprotein E phenotype A report from the multiple risk factor intervention trial
1994
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis
2000
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
2002
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Serum Insulin and Incident Coronary Heart Disease in Middle-aged British Men
1996
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Plasma Uric Acid Level and Risk for Incident Hypertension Among Men
2006
Do Men and Women Fracture Bones at Similar Bone Densities?
2000
The metabolic syndrome
2005 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals
2004
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden
2000
Polycystic Ovary Syndrome
1995 Standout
Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies
2002
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Cost-Effectiveness of Preventing Hip Fracture in the General Female Population
2001
The metabolic syndrome: prevalence in worldwide populations
2004
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 StandoutNature
Syndrome X: A syndrome of insulin resistance. Epidemiological and clinical evidence
1994
Predicting Obesity in Young Adulthood from Childhood and Parental Obesity
1997 Standout
THE ENDOCRINOLOGY OF OBESITY
1996
Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes
1999
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Induction of insulin resistance by androgens and estrogens.
1994
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
The metabolic syndrome—a new worldwide definition
2005 Standout
Exercise and the metabolic syndrome
1997
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
1998 StandoutNature
Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men
2004
Epidemiology of hip fractures: Implications of the exponential increase with age
1996
Correlation between cardiovascular disease and diabetes mellitus: current concepts
2004
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
A meta-analysis of milk intake and fracture risk: low utility for case finding
2004
Evaluation of the risk of hip fracture
1996
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease
1996
The Efficacy of Acamprosate in the Maintenance of Abstinence in Alcohol‐Dependent Individuals: Results of a Meta‐Analysis
2004
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
1990
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
1998 Standout
Alcohol intake as a risk factor for fracture
2004
Evidence for an independent relationship between insulin resistance and fasting plasma HDL‐cholesterol, triglyceride and insulin concentrations
1992
A Placebo‐Controlled, Double‐Blind Study of Fluoxetine in Severe Alcohol Dependence: Adjunctive Pharmacotherapy During and After Inpatient Treatment
1996
Secondary osteoporosis and the risk of distal forearm fractures in men and women
2002
Relationships of generalized and regional adiposity to insulin sensitivity in men.
1995
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Uric acid metabolism and tubular sodium handling. Results from a population-based study.
1993
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals
1999
Relative Contribution of Insulin and Its Precursors to Fibrinogen and PAI-1 in a Large Population With Different States of Glucose Tolerance
1999
Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial
1995
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Developmental effects of endocrine-disrupting chemicals in wildlife and humans.
1993 Standout
Concordance for Dyslipidemic Hypertension in Male Twins
1991
Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques
1998
Relationship to Insulin Resistance of the Adult Treatment Panel III Diagnostic Criteria for Identification of the Metabolic Syndrome
2004
Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
1999
Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
1995
Activation-Induced Autophagy Is Preserved in CD4+ T-Cells in Familial Longevity
2017
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
1999 StandoutScience
Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus
1998
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.
1998
Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
2003
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
Fasting Serum Insulin Levels and Coronary Heart Disease in a Danish Cohort: 17-year Follow-up
1995
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Bone Density Variation and Its Effects on Risk of Vertebral Deformity in Men and Women Studied in Thirteen European Centers: The EVOS Study
1997
Asymptomatic atherosclerosis and insulin resistance.
1991
Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells
1997
Risk factors for hip fracture in european women: The MEDOS study
1995
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Genetic Dissection of Complex Traits
1994 StandoutScience
Visceral Adipose Tissue Is an Independent Correlate of Glucose Disposal in Older Obese Postmenopausal Women1
2000
Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant
2003
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
PHARMACOTHERAPY OF ALCOHOLISM: GAPS IN KNOWLEDGE AND OPPORTUNITIES FOR RESEARCH
2000
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
2005
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
2004
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Immunological changes in simian immunodeficiency virus (SIVagm)-infected African green monkeys (AGM): expanded cytotoxic T lymphocyte, natural killer and B cell subsets in the natural host of SIVagm
2002
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Who Has Osteoporosis? A Conflict Between Clinical and Public Health Perspectives
2000
The diagnosis of osteoporosis
1994 Standout
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome
2003
Persistent Elevation of Plasma Insulin Levels Is Associated With Increased Cardiovascular Risk in Children and Young Adults
1996
The Metabolic Syndrome: Requiescat in Pace
2005
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of M Passeri being referenced
The mediterranean osteoporosis study (MEDOS): Theoretical and practical issues of a major international project on hip fracture epidemiology
1993
High Plasma Insulin and Triglyceride Concentrations and Blood Pressure in Offspring of People with Impaired Glucose Tolerance
1990
Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure
1994
Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose Tolerance
1989
The variable incidence of hip fracture in Southern Europe: The MEDOS study
1994
Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis
1991
The immune system in extreme longevity
2007
Expansion of cytotoxic CD8+ CD28− T cells in healthy ageing people, including centenarians
1996
Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis
1995
Risk Factors for Hip Fracture in Men from Southern Europe: The MEDOS Study
1999
Serotonergic control of TSH and PRL secretion in obese men
1990
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia
1993
Mechanism of Action of Human Calcitonin Gene-Related Peptide in Rabbit Heart and in Human Mammary Arteries
1997
Hyperinsulinaemia, obesity, and syndrome X
1994
Hip fracture in Italy: Epidemiology and preventive efficacy of bone-active drugs
1993
Prevalence of hyperinsulinaemia in patients with high blood pressure
1992
Effects of fluoxetine and ca-acetyl-homotaurinate on alcohol intake in familial and nonfamilial alcoholic patients
1992
Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study
1986
Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.
1996
Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
1990
Impaired dopaminergic modulation of pituitary secretion in workers occupationally exposed to styrene: further evidence from PRL response to TRH stimulation.
1987